The estimated Net Worth of Kathleen M O Donnell is at least $936 Thousand dollars as of 25 October 2004. Kathleen Donnell owns over 2,500 units of Biodelivery Sciences International stock worth over $935,766 and over the last 20 years Kathleen sold BDSI stock worth over $0.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Kathleen Donnell BDSI stock SEC Form 4 insiders trading
Kathleen has made over 16 trades of the Biodelivery Sciences International stock since 2004, according to the Form 4 filled with the SEC. Most recently Kathleen bought 2,500 units of BDSI stock worth $8,875 on 25 October 2004.
The largest trade Kathleen's ever made was buying 25,000 units of Biodelivery Sciences International stock on 27 August 2004 worth over $71,750. On average, Kathleen trades about 8,082 units every 4 days since 2004. As of 25 October 2004 Kathleen still owns at least 167,400 units of Biodelivery Sciences International stock.
You can see the complete history of Kathleen Donnell stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
What's Kathleen Donnell's mailing address?
Kathleen's mailing address filed with the SEC is C/O MCCABE & O'DONNELL, 3101 NORTH CENTRAL AVENUE, SUITE 700, PHOENIX, AZ, 85012.
Insiders trading at Biodelivery Sciences International
Over the last 21 years, insiders at Biodelivery Sciences International have traded over $111,671,776 worth of Biodelivery Sciences International stock and bought 1,813,177 units worth $5,352,510 . The most active insiders traders include International, L.P. Elliott, Associates, L.P. Elliott, and Healthcare Master Fund Ltd .... On average, Biodelivery Sciences International executives and independent directors trade stock every 18 days with the average trade being worth of $420,648. The most recent stock trade was executed by Jeffrey Allen Bailey on 9 March 2022, trading 5,333 units of BDSI stock currently worth $29,811.
What does Biodelivery Sciences International do?
BioDelivery Sciences International, Inc. is a commercial-stage specialty pharmaceutical company dedicated to patients living with chronic conditions. BDSI has built a portfolio of products that includes utilizing its novel and proprietary BioErodible MucoAdhesive (BEMA®) technology to develop and commercialize, either on its own or in partnership with third parties, new applications of proven therapies aimed at addressing important unmet medical needs. BDSI's marketed products address serious and debilitating conditions, including chronic pain and opioid-induced constipation.
What does Biodelivery Sciences International's logo look like?
Complete history of Kathleen Donnell stock trades at Biodelivery Sciences International
Biodelivery Sciences International executives and stock owners
Biodelivery Sciences International executives and other stock owners filed with the SEC include:
-
Scott Plesha,
President, Chief Commercial Officer -
Mary Coelho,
Chief Financial Officer, Treasurer -
Thomas Smith,
Chief Medical Officer -
James Vollins,
Chief Compliance Officer, General Counsel, Corporate Secretary -
Scott M. Plesha,
Pres & Chief Commercial Officer -
James Vollins J.D.,
Gen. Counsel, Chief Compliance Officer & Corp. Sec. -
Dr. Thomas B. Smith FAAFP, M.D.,
Chief Medical Officer -
Vanila Singh,
Independent Director -
Mark Sirgo,
Vice Chairman of the Board -
Todd Davis,
Independent Director -
Peter Greenleaf,
Independent Chairman of the Board -
William Watson,
Independent Director -
Kevin Kotler,
Independent Director -
Kevin Ostrander,
Senior Vice President - Business Development -
Joseph Lockhart,
Senior Vice President - Operations -
Jeffrey Bailey,
Chief Executive Officer -
Dr. Jeff Katz,
Member of Scientific Advisory Board and Member of Arius Scientific Advisory Board -
Dr. Arthur G. Lipman PharmD,
Member of Scientific Advisory Board and Member of Arius Scientific Advisory Board -
Dr. Bill McCarberg,
Member of Scientific Advisory Board and Member of Arius Scientific Advisory Board -
John Golubieski,
CFO & Chief Accounting Officer -
Niraj Vasisht,
Chief Technology Officer -
Samuel P Jr Sears,
Director -
Barry I Feinberg,
Director -
Charles Bramlage,
Director -
William B Stone,
Director -
Francis E Jr Odonnell,
Director -
Thomas D'alonzo,
Director -
Healthcare Master Fund Ltd ...,
-
Timothy Tyson,
Director -
W. Mark Watson,
Director -
Kevin Broadfin Healthcare M...,
-
Herm Cukier,
Chief Executive Officer -
John J Shea,
Director -
Iv Llc Ramsay David Russ Le...,
-
Capital Group Ii Llc Hopkins,
10% owner -
Allan Pearce,
Director -
James R Butler,
Director -
Paolantonio Ernest Robert De,
CFO and Secretary -
Associates, L.P. Elliott,
10% owner -
James A Mcnulty,
Chief Financial Officer -
William Poole,
Director -
Kathleen M Tr Irrev Tr 1 Fb...,
10% owner -
Raphael J Mannino,
Executive Vice President & CSO -
Donald Ferguson,
Director -
Iv Llccdc Operations Llc Ra...,
-
International, L.P. Elliott,
10% owner -
L M Stephenson,
Director -
Capital Group Llc Hopkins,
10% owner -
Kathleen M O Donnell,
10% owner -
Benny Ward,
EVP of Busi. & Strategic Dev. -
John Golubieski,
See Remarks